Hendra virus and Nipah virus animal vaccines

被引:52
|
作者
Broder, Christopher C. [1 ]
Weir, Dawn L. [2 ]
Reid, Peter A. [3 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA
[2] Navy Environm & Prevent Med Unit Six, Joint Base Pearl Harbor, HI 96860 USA
[3] Equine Vet Surg, Brisbane, Qld 4034, Australia
关键词
Paramyxovirus; Henipavirus; Hendra; Nipah; Animal models; Pathogenesis; Vaccine; Antiviral; Monoclonal antibody; EQUINE MORBILLIVIRUS PNEUMONIA; AFRICAN-GREEN MONKEYS; G-GLYCOPROTEIN; HENIPAVIRUS INFECTION; PTEROPID BATS; NEUTRALIZING ANTIBODIES; FATAL ENCEPHALITIS; CLINICAL-FEATURES; FLYING FOXES; PIG-FARMERS;
D O I
10.1016/j.vaccine.2016.03.075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hendra virus (HeV) and Nipah virus (NiV) are zoonotic viruses that emerged in the mid to late 1990s causing disease outbreaks in livestock and people. HeV appeared in Queensland, Australia in 1994 causing a severe respiratory disease in horses along with a human case fatality. NiV emerged a few years later in Malaysia and Singapore in 1998-1999 causing a large outbreak of encephalitis with high mortality in people and also respiratory disease in pigs which served as amplifying hosts. The key pathological elements of HeV and NiV infection in several species of mammals, and also in people, are a severe systemic and often fatal neurologic and/or respiratory disease. In people, both HeV and NiV are also capable of causing relapsed encephalitis following recovery from an acute infection. The known reservoir hosts of HeV and NiV are several species of pteropid fruit bats. Spillovers of HeV into horses continue to occur in Australia and NiV has caused outbreaks in people in Bangladesh and India nearly annually since 2001, making HeV and NiV important transboundary biological threats. NiV in particular possesses several features that underscore its potential as a pandemic threat, including its ability to infect humans directly from natural reservoirs or indirectly from other susceptible animals, along with a capacity of limited human-to-human transmission. Several HeV and NiV animal challenge models have been developed which have facilitated an understanding of pathogenesis and allowed for the successful development of both active and passive immunization countermeasures. Published by Elsevier Ltd.
引用
收藏
页码:3525 / 3534
页数:10
相关论文
共 50 条
  • [31] A Hendra Virus G Glycoprotein Subunit Vaccine Protects African Green Monkeys from Nipah Virus Challenge
    Bossart, Katharine N.
    Rockx, Barry
    Feldmann, Friederike
    Brining, Doug
    Scott, Dana
    LaCasse, Rachel
    Geisbert, Joan B.
    Feng, Yan-Ru
    Chan, Yee-Peng
    Hickey, Andrew C.
    Broder, Christopher C.
    Feldmann, Heinz
    Geisbert, Thomas W.
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (146)
  • [32] Hendra virus
    Young, Jeannette R.
    Selvey, Christine E.
    Symons, Rick
    MEDICAL JOURNAL OF AUSTRALIA, 2011, 195 (05) : 250 - 251
  • [33] Hendra Virus
    Middleton, Deborah
    VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE, 2014, 30 (03) : 579 - +
  • [34] Re: Canine case of Hendra virus and Hendra virus vaccine
    Symons, Rick
    AUSTRALIAN VETERINARY JOURNAL, 2011, 89 (10) : N24 - N24
  • [35] Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes
    Bradel-Tretheway, Birgit G.
    Zamora, J. Lizbeth Reyes
    Stone, Jacquelyn A.
    Liu, Qian
    Li, Jenny
    Aguilar, Hector C.
    JOURNAL OF VIROLOGY, 2019, 93 (13)
  • [36] Crystallization and preliminary crystallographic analysis of the fusion core from two new zoonotic paramyxoviruses, Nipah virus and Hendra virus
    Xu, YH
    Lou, ZY
    Liu, YW
    Cole, DK
    Su, N
    Qin, L
    Li, X
    Bai, ZH
    Rao, ZH
    Gao, GF
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 : 1161 - 1164
  • [37] Recombinant nipah virus vaccines protect pigs against challenge
    Weingartl, Hana M.
    Berhane, Yohannes
    Caswell, Jeff L.
    Loosmore, Sheena
    Audonnet, Jean-Christophe
    Roth, James A.
    Czub, Markus
    JOURNAL OF VIROLOGY, 2006, 80 (16) : 7929 - 7938
  • [38] Immunogenicity of poxvirus-based vaccines against Nipah virus
    Emily S. Medina-Magües
    Jaime Lopera-Madrid
    Michael K. Lo
    Christina F. Spiropoulou
    Joel M. Montgomery
    Lex G. Medina-Magües
    Cristhian Salas-Quinchucua
    Angela P. Jiménez-Mora
    Jorge E. Osorio
    Scientific Reports, 13
  • [39] Immunogenicity of poxvirus-based vaccines against Nipah virus
    Medina-Magues, Emily S.
    Lopera-Madrid, Jaime
    Lo, Michael K.
    Spiropoulou, Christina F.
    Montgomery, Joel M.
    Medina-Magues, Lex G.
    Salas-Quinchucua, Cristhian
    Jimenez-Mora, Angela P.
    Osorio, Jorge E.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [40] Animal models for the study of emerging zoonotic viruses: Nipah and Hendra
    Horvat, Branka
    VETERINARY JOURNAL, 2009, 181 (03): : 207 - 208